Dr. Hyman B. Muss discusses the unique facets of care that should inform personalized treatment decision-making for older ...

Mary Anderson’s lifelong commitment to innovation, education and advocacy improves the lives of patients and empowers her ...

Dr. Andrew M. Evens breaks down what it means to be an adolescent or young adult with lymphoma and how treatment differs from ...

I have worked alongside Carmela Cuccurullo, NP.

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

After cancer, lifelong infusions were tough — until nurse Angela’s care and kindness reminded me that true support can last long after treatment ends.

For Melanoma Awareness Month, Dr. Douglas Johnson explains how stage and features of the disease can guide treatment decisions after diagnosis.